indomethacin has been researched along with Hepatitis, Chronic in 4 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we evaluated the changes on serum 2'5'-oligoadenylate synthetase levels induced by acute administration of interferon-alpha, indomethacin and interferon-alpha plus indomethacin in 21 patients with hepatitis B or C virus chronic active hepatitis." | 7.69 | Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. ( Andreone, P; Buzzi, A; Cursaro, C; Gasbarrini, G; Gramenzi, A; Miniero, R; Sprovieri, G, 1994) |
| " In this study, we evaluated the changes on serum 2'5'-oligoadenylate synthetase levels induced by acute administration of interferon-alpha, indomethacin and interferon-alpha plus indomethacin in 21 patients with hepatitis B or C virus chronic active hepatitis." | 3.69 | Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. ( Andreone, P; Buzzi, A; Cursaro, C; Gasbarrini, G; Gramenzi, A; Miniero, R; Sprovieri, G, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, S | 1 |
| Koga, S | 1 |
| Ibayashi, H | 1 |
| Andreone, P | 1 |
| Cursaro, C | 1 |
| Gramenzi, A | 1 |
| Buzzi, A | 1 |
| Miniero, R | 1 |
| Sprovieri, G | 1 |
| Gasbarrini, G | 1 |
| Kakumu, S | 1 |
| Tahara, H | 1 |
| Fuji, A | 1 |
| Yoshioka, K | 1 |
| Uemura, M | 1 |
| Tsujii, T | 1 |
| Fukui, H | 1 |
| Kita, K | 1 |
| Takaya, A | 1 |
| Tsukamoto, N | 1 |
| Nakayama, M | 1 |
| Matsumoto, M | 1 |
| Tamura, M | 1 |
4 other studies available for indomethacin and Hepatitis, Chronic
| Article | Year |
|---|---|
Interleukin 1 activity in culture supernatant of lipopolysaccharide-stimulated monocytes from patients with chronic liver disease.
Topics: Adult; Aged; Cells, Cultured; Female; Hepatitis, Chronic; Humans; Indomethacin; Interleukin-1; Lipop | 1984 |
Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
Topics: 2',5'-Oligoadenylate Synthetase; Adolescent; Adult; Drug Combinations; Female; Hepatitis Antibodies; | 1994 |
Interleukin 1 alpha production by peripheral blood monocytes from patients with chronic liver disease and effect of sera on interleukin 1 alpha production.
Topics: Carrier State; Hepatitis B; Hepatitis, Chronic; Humans; In Vitro Techniques; Indomethacin; Interfero | 1988 |
Urinary prostaglandins and renal function in chronic liver diseases.
Topics: Adult; Dinoprost; Dinoprostone; Female; Hemodynamics; Hepatitis; Hepatitis, Chronic; Humans; Indomet | 1986 |